Efficacy and Safety of Continuous Infusion of Ketamine in Pediatric Intensive Care Unit (KISS Study)

CompletedOBSERVATIONAL
Enrollment

57

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

July 31, 2021

Study Completion Date

September 1, 2021

Conditions
AnalgesiaKetamine ToxicityBronchospasmSedation Complication
Trial Locations (1)

35127

Azienda Ospedale Università Padova, Padua

All Listed Sponsors
lead

Azienda Ospedaliera di Padova

OTHER

NCT04427605 - Efficacy and Safety of Continuous Infusion of Ketamine in Pediatric Intensive Care Unit (KISS Study) | Biotech Hunter | Biotech Hunter